First Allied Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

First Allied Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$8.73M	Buy	144,726 +1,796	+1%	+$108K	0.29%	75
2020 Q2	$8.4M	Buy	142,930 +4,612	+3%	+$276K	0.31%	73
2020 Q1	$7.71M	Sell	138,318 -60	-0%	-$3.67K	0.33%	63
2019 Q4	$8.88M	Buy	138,378 +61,966	+81%	+$3.55M	0.3%	74
2019 Q3	$3.86M	Sell	76,412 -7,839	-9%	-$368K	0.14%	175
2019 Q2	$3.82M	Sell	84,251 -237	-0.3%	-$11K	0.13%	185
2019 Q1	$4.04M	Buy	84,488 +2,918	+4%	+$145K	0.14%	177
2018 Q4	$4.24M	Buy	81,570 +4,810	+6%	+$258K	0.17%	151
2018 Q3	$4.76M	Buy	76,760 +7,074	+10%	+$420K	0.16%	151
2018 Q2	$3.87M	Sell	69,686 -9,004	-11%	-$486K	0.15%	175
2018 Q1	$4.99M	Buy	78,690 +2,761	+4%	+$178K	0.19%	136
2017 Q4	$4.65M	Buy	75,929 +116	+0.2%	+$7.25K	0.19%	132
2017 Q3	$4.84M	Buy	75,813 +1,675	+2%	+$97.8K	0.21%	125
2017 Q2	$4.14M	Buy	74,138 +5,968	+9%	+$325K	0.18%	140
2017 Q1	$3.78M	Buy	68,170 +2,931	+4%	+$161K	0.2%	121
2016 Q4	$3.81M	Buy	65,239 +5,435	+9%	+$297K	0.19%	127
2016 Q3	$3.23M	Buy	59,804 +8,720	+17%	+$560K	0.17%	144
2016 Q2	$3.76M	Sell	51,084 -11,472	-18%	-$811K	0.21%	122
2016 Q1	$4M	Buy	62,556 +345	+0.6%	+$21.8K	0.22%	112
2015 Q4	$4.28M	Sell	62,211 -18,123	-23%	-$1.2M	0.22%	106
2015 Q3	$4.78M	Sell	80,334 -1,192	-1%	-$75.6K	0.26%	100
2015 Q2	$5.43M	Buy	81,526 +3,321	+4%	+$219K	0.24%	109
2015 Q1	$5.02M	Buy	78,205 +17,676	+29%	+$1.11M	0.33%	65
2014 Q4	$3.58M	Sell	60,529 -70,572	-54%	-$3.98M	0.26%	87
2014 Q3	$6.7M	Sell	131,101 -20,610	-14%	-$1.03M	0.53%	31
2014 Q2	$7.38M	Buy	151,711 +9,760	+7%	+$481K	0.54%	34
2014 Q1	$7.39M	Sell	141,951 -963	-0.7%	-$51.2K	0.55%	27
2013 Q4	$7.61M	Sell	142,914 -8,509	-6%	-$433K	0.61%	18
2013 Q3	$7.02M	Sell	151,423 -1,119	-0.7%	-$49.1K	0.41%	58
2013 Q2	$6.81M	Buy	+152,542	New	+$6.62M	0.54%	29

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

First Allied Advisory Services's BMY Position: Q3 2020 in Review

First Allied Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q3 2020, buying an estimated $108K and bringing the position to 144,726 shares worth $8.73M. The position accounts for 0.29% of the portfolio, ranked #75.

First Allied Advisory Services first reported a position in BMY in Q2 2013 and has held it in 30 quarters since. The position peaked at $8.88M in Q4 2019. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

First Allied Advisory Services held 144,726 shares of Bristol-Myers Squibb worth $8.73M as of Q3 2020.
First Allied Advisory Services bought 1,796 Bristol-Myers Squibb shares in Q3 2020, an estimated $108K.
Bristol-Myers Squibb made up 0.29% of First Allied Advisory Services's portfolio in Q3 2020, its #75 holding.
First Allied Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 30 quarters since.
First Allied Advisory Services's Bristol-Myers Squibb position peaked at $8.88M in Q4 2019.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.